Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Conditions News
FDA approves Livmarli for pruritus in progressive familial intrahepatic cholestasis
The FDA has approved Mirum Pharmaceuticals’ Livmarli oral solution for treatment of cholestatic pruritus in patients aged 5 years and older with progressive familial intrahepatic cholestasis, according to a company release.
Postoperative antibiotics do not improve nonperforated appendicitis outcomes in children
Postoperative antibiotic use did not improve rates of surgical site infection among pediatric patients with nonperforated appendicitis and gangrenous, suppurative or exudative findings, according to data in JAMA Surgery.
Log in or Sign up for Free to view tailored content for your specialty!
Continuation of Stelara during pregnancy ‘of low risk’ to women with IBD, offspring
Treatment with Stelara for inflammatory bowel disease did not increase the risk for adverse maternal or fetal pregnancy outcomes, and infants exposed in utero reached developmental milestones in the first year of life, data showed.
Diagnostic stewardship helps reduce C. difficile at children’s hospital
Diagnostic stewardship, along with targeted prevention efforts and a testing and treatment clinical care pathway, reduced hospital-onset cases of Clostridioides difficile by more than 50% in a children’s hospital, researchers reported.
Linaclotide improves rate of bowel movements, consistency in children with constipation
Treatment with once-daily linaclotide was well-tolerated and resulted in significant improvement in spontaneous bowel movements and stool consistency vs. placebo among children with functional constipation, researchers reported.
Prebiotic inulin causes ‘beneficial changes’ in microbiome of children with IBD
LAS VEGAS — Supplementation with prebiotic oligofructose-enriched inulin resulted in short-term microbiome changes as early as 4 weeks among children with inflammatory bowel disease, according to a presenter at Crohn’s & Colitis Congress.
Anti-TNF therapy significantly improves growth disturbances in pediatric Crohn’s
LAS VEGAS — Although a substantial proportion of children with Crohn’s disease had growth disturbances at initiation of anti-tumor necrosis factor therapy, “significant improvement” was noted up to 24 months after treatment, data showed.
One-dose typhoid conjugate vaccine provides lasting protection
A single dose of a typhoid conjugate vaccine provided protection for at least 4 years among children aged 9 months to 12 years enrolled in a phase 3 trial in Malawi, according to results published in The Lancet.
Single dose of oral cholera vaccine effective for at least 36 months
A single dose of Eubiologics’s oral cholera vaccine provided significant protection against cholera for at least 36 months, according to data from a vaccination campaign organized in a cholera-endemic city in Africa.
Multidisciplinary care teams ‘critical’ for the treatment of very early-onset IBD
LAS VEGAS — Collaborative, multidisciplinary care strategies optimize the treatment and management of patients with very early-onset inflammatory bowel disease, a presenter reported at the Crohn’s & Colitis Congress.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read